Control of elongation by RNA polymerase II

Trends in Biochemical Sciences

Volumn 25, Issue 8, 2000, Pages 375-380

  Conaway, Joan W ^a   Shilatifard, Ali ^b   Dvir, Arik ^c   Conaway, Ronald C ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; INITIATION FACTOR; INITIATION FACTOR TFIIE; INITIATION FACTOR TFIIF; INITIATION FACTOR TFIIH; MESSENGER RNA; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CARBOXY TERMINAL SEQUENCE; CHROMATIN STRUCTURE; CONTROL SYSTEM; CRYSTAL STRUCTURE; ENZYME SUBUNIT; EUKARYOTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; RNA TRANSLATION; TRANSCRIPTION INITIATION;

CHROMATIN; GENE EXPRESSION REGULATION; MODELS, BIOLOGICAL; RNA POLYMERASE II; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0034255861     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(00)01615-7     Document Type: Review

References (59)

1. Cramer P.et al. Architecture of RNA polymerase II and implications for the transcription mechanism. Science. 288:2000;640-649.
2. Wind M., Reines D. Transcription elongation factor SII. BioEssays. 22:2000;327-336.
3. Roeder R.G. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:1996;327-335.
4. Tirode F.et al. Reconstitution of the transcription factor TFIIH: Assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol. Cell. 3:1999;87-95.
5. Keene R.G., Luse D.S. Initially transcribed sequences strongly affect the extent of abortive initiation by RNA polymerase II. J. Biol. Chem. 274:1999;11526-11534.
6. Holstege F.C.P.et al. Three transitions in the RNA polymerase II transcription complex during initiation. EMBO J. 16:1997;7468-7480.
7. Price D.H.et al. Dynamic interaction between a Drosophila transcription factor and RNA polymerase II. Mol. Cell. Biol. 9:1989;1465-1475.
8. Yan Q.et al. Dual roles for TFIIF in promoter escape by RNA polymerase II. J. Biol. Chem. 274:1999;35668-35675.
9. Dvir A.et al. Promoter escape by RNA polymerase II: A role for an ATP cofactor in suppression of arrest by polymerase at promoter-proximal sites. J. Biol. Chem. 271:1996;23352-23356.
10. Dvir A.et al. A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. Proc. Natl. Acad. Sci. U. S. A. 94:1997;9006-9010.
11. Kugal J.F., Goodrich J.A. Promoter escape limits the rate of RNA polymerase II transcription and is enhanced by TFIIE, TFIIH, and ATP on negatively supercoiled DNA. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9232-9237.
12. Kumar K.P.et al. Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9767-9772.
13. Moreland R.J.et al. A role for the TFIIH XPB DNA helicase in promoter escape by RNA polymerase II. J. Biol. Chem. 274:1999;22127-22130.
14. Bradsher J.et al. Distinct roles for the helicases of TFIIH in transcript initiation and promoter escape. J. Biol. Chem. 275:2000;2532-2538.
15. Dvir A.et al. A role for ATP and TFIIH in activation of the RNA polymerase II preinitiation complex prior to transcription initiation. J. Biol. Chem. 271:1996;7245-7248.
16. Robert F.et al. Wrapping of promoter DNA around the RNA polymerase II initiation complex induced by TFIIF. Mol. Cell. 2:1998;342-351.
17. Fu J.et al. Repeated tertiary fold of RNA polymerase II and implications for DNA binding. J. Mol. Biol. 280:1998;317-322.
18. Tan S.et al. A cryptic DNA binding domain in the C-terminus of RNA polymerase II general transcription factor RAP30. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9808-9812.
19. Groft C.M.et al. Structural homology between the Rap30 DNA-binding domain and linker histone H5: implications for preinitiation complex assembly. Proc. Natl. Acad. Sci. U. S. A. 95:1998;9117-9122.
20. Dahmus M.E. Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271:1996;19009-19012.
21. Chodosh L.A.et al. 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264:1989;2250-2257.
22. Marshall N.F., Price D.H. Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12:1992;2078-2090.
23. Marshall N.F., Price D.H. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:1995;12335-12338.
24. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634.
25. Yamaguchi Y.et al. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Cell. 97:1999;41-51.
26. Wada T.et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12:1998;343-356.
27. Marshall N.F.et al. Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 271:1996;27176-27183.
28. Zhu Y.et al. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:1997;2622-2632.
29. Mancebo H.S.Y.et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev. 11:1998;2633-2644.
30. Peng J.et al. Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12:1998;755-762.
31. Fu T.J.et al. Cyclin K functions as a cdk9 regulatory subunit and participates in RNA polymerase II transcription. J. Biol. Chem. 274:1999;34527-34530.
32. Hartzog G.A.et al. Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12:1998;357-369.
33. Wei P.et al. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell. 92:1998;451-462.
34. Parada C.A., Roeder R.G. A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription. EMBO J. 18:1999;3688-3701.
35. Uptain S.M.et al. Basic mechanisms of transcript elongation and its regulation. Annu. Rev. Biochem. 66:1997;117-172.
36. Lennon J.C.et al. Mutations in RNA polymerase II and elongation factor SII severely reduce mRNA levels in Saccharomyces cerevisiae. Mol. Cell. Biol. 18:1998;5771-5779.
37. Conaway J.W., Conaway R.C. Transcription elongation and human disease. Annu. Rev. Biochem. 68:1999;301-319.
38. Shilatifard A. Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J. 12:1998;1437-1446.
39. Selby C.P., Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11205-11209.
40. Li X.Y., Green M.R. The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor. Genes Dev. 12:1998;2992-2996.
41. Sune C., Garcia-Blanco M.A. Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box dependent manner. Mol. Cell. Biol. 19:1999;4719-4728.
42. Shilatifard A. Identification and purification of the Holo-ELL complex. J. Biol. Chem. 273:1998;11212-11217.
43. Schmidt A.E.et al. Cloning and characterization of the EAP30 subunit of the ELL complex that confers derepression of transcription by RNA polymerase II. J. Biol. Chem. 274:1999;21981-21985.
44. Izban M.G., Luse D.S. Factor-stimulated RNA polymerase II transcribes at physiological elongation rates on naked DNA but very poorly on chromatin templates. J. Biol. Chem. 267:1992;13647-13655.
45. Moreland R.J.et al. Mechanism of action of RNA polymerase II elongation factor Elongin: Maximal stimulation of elongation requires conversion of the early elongation complex to an Elongin-activatable form. J. Biol. Chem. 273:1998;26610-26617.
46. Brown S.A.et al. Activator-dependent regulation of transcriptional pausing on nucleosomal templates. Genes Dev. 10:1996;1479-1490.
47. Ding H.F.et al. Stimulation of RNA polymerase II elongation by chromosomal protein HMG-14. Science. 265:1994;796-799.
48. Orphanides G.et al. FACT, a factor that facilitates transcript elongation through nucleosomes. Cell. 92:1998;105-116.
49. Wittschieben B.O.et al. A novel histone acetyltransferase is an integral subunit of elongating RNA polymerase II holoenzyme. Mol. Cell. 4:1999;123-128.
50. Piruat J.I., Aguilera A. A novel yeast gene, THO2, is involved in RNA pol II transcription and provides new evidence for transcriptional elongation-associated recombination. EMBO J. 17:1998;4859-4872.
51. Bentley D. Coupling RNA polymerase II transcription with pre-mRNA processing. Curr. Opin. Cell Biol. 11:1999;347-351.
52. Shilatifard A.et al. The human ELL gene encodes a novel RNA polymerase II elongation factor. Science. 271:1996;1873-1876.
53. Shilatifard A.et al. ELL2, a new member of an ELL family of RNA polymerase II elongation factors. Proc. Natl. Acad. Sci. U. S. A. 94:1997;3639-3643.
54. Aso T.et al. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science. 269:1995;1439-1443.
55. Aso T.et al. Identification and characterization of Elongin A2, a new member of the Elongin family of transcription elongation factors, specifically expressed in the testis. J. Biol. Chem. 275:2000;6546-6552.
56. Liu M.et al. A human RNA polymerase II transcription termination factor is a SWI2/SNF2 family member. J. Biol. Chem. 273:1998;25541-25544.
57. Ding H.F.et al. Alleviation of histone H1-mediated transcriptional repression and chromatin compaction by the acidic activation region in chromosomal protein HMG-14. Mol. Cell. Biol. 17:1997;5843-5855.
58. Zhou Q., Sharp P.A. Tat-SF1: Cofactor for stimulation of transcriptional elongation by HIV-1 Tat. Science. 274:1996;605-610.
59. Conaway J.W., Conaway R.C. Structural biology. Light at the end of the channel. Science. 288:2000;632-633.